dummies
 

Suchen und Finden

Titel

Autor/Verlag

Inhaltsverzeichnis

Nur ebooks mit Firmenlizenz anzeigen:

 

Foundations of Regenerative Medicine - Clinical and Therapeutic Applications

Anthony Atala

 

Verlag Elsevier Reference Monographs, 2009

ISBN 9780123785626 , 823 Seiten

Format PDF, ePUB, OL

Kopierschutz DRM

Geräte

80,95 EUR

  • Zuweisermarketing für niedergelassene Spezialisten - Allgemeinmediziner professionell gewinnen und binden
    Re-Institutionalisierung statt De-Institutionalisierung in der Behindertenhilfe - Neubestimmung der Funktion von Wohneinrichtungen für erwachsene Menschen mit geistiger Behinderung
    Analysis of Complex Disease Association Studies - A Practical Guide
    Spinal Imaging - Diagnostic Imaging of the Spine and Spinal Cord
    Percutaneous Tumor Ablation in Medical Radiology
    Neurological and Psychiatric Disorders
    Health-Care Telematics in Germany - Design and Application of a Security Analysis Method
    Autonomy and Human Rights in Health Care - An International Perspective
  • Lung Pathology
    Therapiehandbuch Gynäkologie und Geburtshilfe
    Psychological Challenges to Obstetrics and Gynecology - The Clinical Management
    Dopplersonographie in Geburtshilfe und Gynäkologie
    Sexual Health and Genital Medicine in Clinical Practice
    Systemische Malignomtherapie in der Gynäkologischen Onkologie - Ein Leitfaden für Ärzte und Pflegepersonen
    Personalmanagement im Gesundheitsbetrieb - Betriebswirtschaft für das Gesundheitswesen
    Immobilienwirtschaftliche Bewertung von Krankenhäusern nach Einführung der DRG
 

 

Front Cover

1

Foundations of Regenerative Medicine

4

Copyright Page

5

Contents

8

Preface

12

List of Contributors

24

Part I: Introduction to Regenerative Medicine

30

Chapter 1. Current and Future Perspectives of Regenerative Medicine

31

REGENERATIVE MEDICINE: CURRENT AND FUTURE PERSPECTIVES

31

CONCLUSIONS

39

REFERENCES

39

Chapter 2. Fundamentals of Cell-Based Therapies

45

INTRODUCTION

45

RATIONALE FOR CELL-BASED THERAPIES

45

CONCLUSIONS

52

ACKNOWLEDGMENTS

53

REFERENCES

53

Chapter 3. Stem Cell Research

57

INTRODUCTION

57

STEM CELLS

58

STEM CELL MODULATION IN VITRO

64

REGENERATIVE MEDICINE

67

CONCLUSION

71

ACKNOWLEDGMENTS

71

INTERNET RESOURCES

71

REFERENCES

71

Part II: Biologic and Molecular Basis for Regenerative Medicine

78

Chapter 4. Molecular Organization of Cells

79

INTRODUCTION

79

CELLULAR MECHANISMS OF THE EMT

79

MOLECULAR CONTROL OF THE EMT

82

CONCLUSION

88

REFERENCES

88

Chapter 5. Cell–ECM Interactions in Repair and Regeneration

95

INTRODUCTION

95

COMPOSITION AND DIVERSITY OF THE ECM

95

RECEPTORS FOR ECM MOLECULES

97

SIGNAL TRANSDUCTION EVENTS DURING CELL–ECM INTERACTIONS

99

CELL–ECM INTERACTIONS DURING HEALING OF SKIN WOUNDS

102

CELL–ECM INTERACTIONS DURING REGENERATION

107

IMPLICATIONS FOR REGENERATIVE MEDICINE

112

REFERENCES

113

Chapter 6. Developmental Mechanisms of Regeneration

129

INTRODUCTION

129

MECHANISMS OF REGENERATION

130

STRATEGIES OF REGENERATIVE MEDICINE

138

CONCLUSION

146

ACKNOWLEDGMENT

147

REFERENCES

147

Chapter 7. The Molecular Basis of Pluripotency in Principles of Regenerative Medicine

155

INTRODUCTION TO PLURIPOTENCY

155

EXTRACELLULAR SIGNALING FACTORS AND SIGNAL TRANSDUCTION

156

TRANSCRIPTIONAL NETWORKS

160

EPIGENETIC AND ENVIRONMENTAL REGULATION

160

SUMMARY AND PERSPECTIVES

161

REFERENCES

162

Part III: Cells and Tissue Development

166

Chapter 8. Embryonic Stem Cells: Derivation and Properties

167

INTRODUCTION

167

DERIVATION OF ES CELLS

167

CULTURE OF ES CELLS

169

DEVELOPMENTAL POTENTIAL OF ES CELLS

172

CONCLUSION

174

ACKNOWLEDGMENT

175

REFERENCES

175

Chapter 9. Stem Cells Derived from Amniotic Fluid and Placenta

183

INTRODUCTION

183

CVS AND AMNIOCENTESIS

183

DIFFERENTIATED CELLS FROM AMNIOTIC FLUID AND PLACENTA

184

MESENCHYMAL CELL FROM PLACENTA AND AMNIOTIC FLUID

184

PLURIPOTENT STEM CELLS FROM PLACENTA AND AMNIOTIC FLUID

187

FUTURE DIRECTION

192

SUMMARY

192

REFERENCES

192

Chapter 10. Bone Marrow Stem Cells: Properties and Pluripotency

195

INTRODUCTION

195

BONE MARROW STEM CELLs

195

BMSCS AND TISSUE REGENERATION

199

IMPORTANT FACTORS REGULATING BMSC HOMING AND DIFFERENTIATION

202

CLINICAL APPLICATIONS OF BMSCS FOR CARDIAC REGENERATION

205

CONCLUSION

205

REFERENCES

206

Chapter 11. Mesenchymal Stem Cells

211

INTRODUCTION

211

THE DEFINITION OF MSCs

212

THE STEM CELL NATURE OF MSCs

213

SOURCE OF MSCs AND ISOLATION TECHNIQUES

214

WHICH TISSUES CONTAIN MSCs?

215

SKELETAL TISSUE REGENERATION BY MSCs

215

IMMUNOMODULATORY EFFECTS OF MSCs

221

NONSKELETAL TISSUE REGENERATION BY MSCs

223

CONCLUSIONS

225

REFERENCES

226

Chapter 12. Islet Cell Therapy and Pancreatic Stem Cells

237

INTRODUCTION

237

BENEFITS OF β-CELL REPLACEMENT THERAPY

238

CURRENT LIMITATIONS TO β-CELL REPLACEMENT THERAPY

240

ALTERNATIVE SOURCES OF INSULIN-PRODUCING CELLS: STEM CELLS AND β-CELL REGENERATION

241

PANCREATIC DEVELOPMENT

242

ISLET NEOGENESIS FROM ES CELLS

243

ISLET NEOGENESIS FROM ADULT STEM CELLS

244

TRANSDIFFERENTIATION

246

WHAT THE FUTURE MAY HOLD

247

ACKNOWLEDGMENTS

248

REFERENCES

248

Chapter 13. Mechanical Determinants of Tissue Development

257

INTRODUCTION

257

MECHANICAL FORCES EXPERIENCED BY TISSUES

258

THE CELL AS A SIGNAL RECEIVER AND PROCESSOR

260

OVERVIEW OF BIOREACTORS

267

PRACTICAL EXAMPLES OF MECHANICAL DETERMINANTS

268

CONCLUSION

272

REFERENCES

272

Chapter 14. Morphogenesis and Morphogenetic Proteins

275

INTRODUCTION

275

BMPs

276

STEM CELLS

280

SCAFFOLDS OF BIOMIMETIC BIOMATERIALS

282

CARTILAGE-DERIVED MORPHOGENETIC PROTEINS

283

REGENERATIVE MEDICINE AND SURGERY

283

ACKNOWLEDGMENTS

285

REFERENCES

285

Chapter 15. Physical Stress as a Factor in Tissue Growth and Remodeling

289

INTRODUCTION

289

STRUCTURAL HIERARCHY AND THE CONTINUUM CONCEPT

290

STRAIN AND STRESS DEFINITIONS

290

TISSUE GROWTH, REPAIR, AND REMODELING

296

MECHANOTRANSDUCTION MECHANISMS

298

IN VITRO MECHANICAL CONDITIONING

302

CONCLUSIONS

307

REFERENCES

307

Chapter 16. Engineering Cellular Microenvironments

313

INTRODUCTION

313

DEFINING THE CELLULAR MICROENVIRONMENT

314

DEFINING THE ORGANIZATION OF MULTICELLULAR CONSTRUCTS

321

DYNAMICALLY CHANGING THE MICROENVIRONMENT

325

CONCLUSIONS AND FUTURE DIRECTIONS

326

ACKNOWLEDGMENTS

327

REFERENCES

327

Chapter 17. Applications of Nanotechnology

331

INTRODUCTION

331

NANOTECHNOLOGY AS A MULTI-FUNCTIONAL TOOL FOR CELL-BASED THERAPIES

333

NANOTECHNOLOGY AS A MULTI-FUNCTIONAL TOOL FOR BIOMATERIAL CONTROL

335

CONCLUSION

336

REFERENCES

337

Part IV: Biomaterials for Regenerative Medicine

340

Chapter 18. Design Principles in Biomaterials and Scaffolds

341

INTRODUCTION

341

SELECTION OF BIOMATERIALS

342

BIODEGRADABLE SYNTHETIC POLYMERS

342

DESIGN PRINCIPLES OF BIOLOGICAL SCAFFOLDS

343

SUMMARY AND CONCLUSION

351

REFERENCES

352

Chapter 19. Naturally Occurring Scaffold Materials

355

INTRODUCTION

355

COLLAGEN

355

CHITOSAN

356

INTACT EXTRACELLULAR MATRIX AS A SCAFFOLD MATERIAL

358

REFERENCES

359

Chapter 20. Synthetic Polymers

365

INTRODUCTION

365

NON-DEGRADABLE SYNTHETIC POLYMERS

367

BIODEGRADABLE SYNTHETIC POLYMERS FOR REGENERATIVE MEDICINE

374

APPLICATIONS OF SYNTHETIC POLYMERS

386

CONCLUSION/ SUMMARY

387

REFERENCES

387

Chapter 21. Surface Modification of Biomaterials

397

INTRODUCTION

397

PHYSICOCHEMICAL SURFACE MODIFICATIONS

398

OVERCOATING TECHNOLOGIES

401

BIOLOGICAL MODIFICATION OF SURFACES

403

SURFACE CHEMICAL PATTERNING

405

CONCLUSION AND FUTURE PROSPECTS

405

REFERENCES

406

Chapter 22. Biocompatibility and Bioresponse to Biomaterials

407

INTRODUCTION

407

INFLAMMATION (INNATE IMMUNITY) AND WOUND HEALING

408

FIBROSIS AND FIBROUS ENCAPSULATION

416

IMMUNOTOXICITY (ACQUIRED IMMUNITY)

417

SUMMARY

423

REFERENCES

424

Part V: Therapeutic Applications: Cell Therapy

428

Chapter 23. Islet Cell Transplantation

429

INTRODUCTION

429

CLINICAL ISLET TRANSPLANTATION

433

RISKS TO THE RECIPIENT

435

FUTURE CHALLENGES

436

SUMMARY AND CONCLUSIONS

441

REFERENCES

442

Chapter 24. Cell-Based Repair for Cardiovascular Regeneration and Neovascularization: What, Why, How, and Where Are We Going in the Next 5–10 Years?

447

INTRODUCTION

447

THE STATE OF CELL THERAPY

448

CELL-BASED REPAIR AS A MEANS OF REGENERATION IN CVD

449

VASCULAR INTEGRITY IS A BALANCING ACT IN WHICH INFLAMMATION IS KEY: INJURY VERSUS REPAIR

450

REPARATIVE POTENTIAL OF CELL THERAPY

455

CLINICAL STUDIES

466

WHAT IS REQUIRED FOR SUCCESSFUL REPAIR IN 2007 AND BEYOND?

469

SUMMARY

474

ACKNOWLEDGMENTS

475

REFERENCES

475

Chapter 25. Cell Therapies for Bone Regeneration

487

INTRODUCTION

487

CURRENT SOURCES OF OSTEOGENIC CELLS AND CELL ISOLATION TECHNIQUES

491

PRECLINICAL AND CLINICAL RESULTS

495

CONCLUSION: FUTURE DEVELOPMENTS AND CHALLENGES

502

REFERENCES

503

Chapter 26. Cell-Based Therapies for Musculoskeletal Repair

507

INTRODUCTION

507

BIOLOGY OF CELLS IN MUSCULOSKELETAL TISSUES

507

EMBRYONIC AND ADULT STEM CELLS

509

CELL-BASED THERAPIES AND TISSUE ENGINEERING

515

CONCLUSIONS AND PROSPECTS

524

ACKNOWLEDGMENTS

525

REFERENCES

525

Chapter 27. Hepatocyte Transplantation

531

INTRODUCTION

531

BACKGROUND STUDIES

533

CLINICAL HEPATOCYTE TRANSPLANTATION

535

HEPATOCYTE TRANSPLANTATION NOVEL USES, CHALLENGES, AND FUTURE DIRECTIONS

540

SUMMARY

541

REFERENCES

542

Chapter 28. Cell-Based Drug Delivery

547

INTRODUCTION

547

CELLS AND CELL PRODUCTS AS DRUG SOURCES

547

CELL ENCAPSULATION FOR THERAPEUTIC DELIVERY MACHINERY

548

CELL-BASED PROTEIN FACTORY

553

DRUG-LOADED TUMOR CELL SYSTEM

554

SUMMARY

556

REFERENCES

556

Part VI: Therapeutic Applications: Tissue Therapy

560

Chapter 29. Engineering of Large Diameter Vessels

561

INTRODUCTION

561

PREVALENCE AND IMPACT OF VASCULAR DISEASE

561

THE NEED FOR IMPROVED DIALYSIS VASCULAR ACCESS

562

VASCULAR PHYSIOLOGY RELEVANT TO TEBVs

563

TISSUE-ENGINEERED VASCULAR GRAFTS: A BRIEF REVIEW OF THE LITERATURE

567

TISSUE-ENGINEERED VASCULAR GRAFTS: A BRIEF REVIEW OF THE PROCESS

568

REFERENCES

578

Chapter 30. Cardiac Tissue

583

INTRODUCTION: FROM TISSUES TO ORGANS: KEY GOALS AND ISSUES

583

CELL AND GENE THERAPY

584

SCAFFOLD-BASED APPROACHES

587

TISSUE AND ORGAN FUNCTION

591

BIOREACTORS AND CONDITIONING

595

IMPLANTATION OF CARDIAC PATCHES

597

SUMMARY

598

REFERENCES

598

Chapter 31. Intracorporeal Kidney Support

605

INTRODUCTION

605

BASIC PRINCIPLES OF KIDNEY TISSUE REGENERATION

605

CREATION OF RENAL STRUCTURES IN VIVO

607

REGENERATION OF FUNCTIONAL RENAL TISSUE IN VIVO

608

SUMMARY

610

REFERENCES

610

Chapter 32. Genitourinary System

613

INTRODUCTION

613

RECONSTITUTION STRATEGIES

613

THE ROLE OF BIOMATERIALS

613

VASCULARIZATION

614

PROGRESS IN TISSUE ENGINEERING OF UROLOGIC STRUCTURES

614

ADDITIONAL APPLICATIONS

619

CONCLUSION

621

ACKNOWLEDGMENTS

622

REFERENCES

622

Chapter 33. Tissue Engineering of the Reproductive System

625

INTRODUCTION

625

MALE

626

FEMALE

639

REFERENCES

646

Chapter 34. Phalanges and Small Joints

651

INTRODUCTION

651

BASIC PRINCIPLES OF ENGINEERING PHALANGES AND SMALL JOINTS

652

CREATION OF COMPOSITE TISSUE STRUCTURES

654

SUMMARY AND FUTURE PERSPECTIVES IN CLINICAL TRANSLATION

656

REFERENCES

657

Chapter 35. Functional Tissue Engineering of Ligament and Tendon Injuries

659

INTRODUCTION

659

NORMAL LIGAMENTS AND TENDONS

660

HEALING OF LIGAMENTS AND TENDONS

664

MCL OF THE KNEE

665

APPLICATION OF FTE

667

SUMMARY AND FUTURE DIRECTIONS

674

ACKNOWLEDGMENT

675

REFERENCES

675

Chapter 36. Tissue Therapy: Implications of Regenerative Medicine for Skeletal Muscle

685

INTRODUCTION

685

THE NATURAL HEALING PROCESS OF SKELETAL MUSCLE

685

THE ROLE OF INFLAMMATION IN SKELETAL MUSCLE HEALING

688

PROMOTING REGENERATION AFTER SKELETAL MUSCLE INJURY

691

FIBROSIS PREVENTION: ANOTHER APPROACH TO IMPROVING SKELETAL MUSCLE HEALING

693

CONCLUSION

694

REFERENCES

695

Chapter 37. Peripheral Nerve Regeneration

701

INTRODUCTION

701

ISOTROPIC NERVE GRAFTS FOR REGENERATION

703

ANISOTROPIC NERVE GRAFTS

709

NATURAL NERVE GRAFTS

710

ANIMAL MODELS

711

SUMMARY

712

REFERENCES

712

Chapter 38. Innovative Regenerative Medicine Approaches to Skin Cell-Based Therapy for Patients with Burn Injuries

717

INTRODUCTION

717

CONVENTIONAL THERAPY AND CURRENT COMMERCIAL PRODUCTS

717

PROBLEMS IN THE FIELD

720

CELL APPLICATION INTO THE WOUND BY SPRAYING

721

PATIENT GROUPS AND SELECTION CRITERIA FOR CLINICAL STUDIES IN THE FIELD OF SKIN CELL-BASED THERAPY DEVELOPMENT IN BURN DISEASE PATIENTS

722

INITIAL OWN CASE REPORTS SHOW THAT THE SPRAY TRANSPLANTATION METHOD WITH IN VITRO EXPANDED KERATINOCYTES YIELDS AN IMPROVED OUTCOME OF DEEP DERMAL BURN INJURIES ON…

724

SKIN PROGENITOR CELLS

726

REGULATORY ISSUES

728

DISCUSSION

733

ACKNOWLEDGMENT

735

REFERENCES

735

Part VII: Regulations and Ethics

742

Chapter 39. Ethical Considerations

743

ARGUMENTS THAT DO NOT WORK

743

ARGUMENTS THAT WORK

747

MORALITY AND THE SCOPE OF FUNDED RESEARCH

751

ETHICAL CONSTRAINTS

751

ACKNOWLEDGMENT

752

REFERENCES

753

Chapter 40. To Make is to Know: The Ethical Issues in Human Tissue Engineering

755

CASE STUDY

755

ARE THERE REASONS IN PRINCIPLE WHY PERFORMING THE BASIC RESEARCH SHOULD BE IMPERMISSIBLE?

756

DUTY AND HEALING: NATURAL MAKERS IN A BROKEN WORLD

757

TO MAKE IS TO KNOW: NOTES ON AN OLD PROBLEM ABOUT KNOWLEDGE

758

WHAT IS A THING: THE PERILS OF DECONSTRUCTION?

759

WHAT CONTEXTUAL FACTORS SURROUNDING THE TECHNOLOGY HAVE TO BE TAKEN INTO ACCOUNT AND DO ANY OF THESE PREVENT THE DEVELOPMENT AND USE OF THE TECHNOLOGY?

759

WHAT PURPOSES, TECHNIQUES, OR APPLICATIONS WOULD BE PERMISSIBLE AND UNDER WHAT CIRCUMSTANCES?

760

WHAT PROCEDURES, STRUCTURES, INVOLVING WHAT POLICIES, SHOULD BE USED TO DECIDE ON APPROPRIATE TECHNIQUES AND USES?

761

CONCLUSION

762

Chapter 41. Overview of FDA Regulatory Process

763

INTRODUCTION AND CHAPTER OVERVIEW

763

BRIEF LEGISLATIVE HISTORY OF FDA

763

LAWS, REGULATIONS, AND GUIDANCE

764

FDA ORGANIZATION AND JURISDICTIONAL ISSUES

766

APPROVAL MECHANISMS AND CLINICAL STUDIES

767

MEETINGS WITH INDUSTRY, PROFESSIONAL GROUPS, AND SPONSORS

768

REGULATIONS AND GUIDANCE OF SPECIAL INTEREST FOR REGENERATIVE MEDICINE

769

ADVISORY COMMITTEE MEETINGS

776

FDA AND CRITICAL PATH SCIENCE

777

CONCLUSION

778

REFERENCES

778

Chapter 42. Current Issues in US Patent Law

783

WHAT ARE INTELLECTUAL PROPERTY RIGHTS?

783

WHY ARE INTELLECTUAL PROPERTY RIGHTS IMPORTANT?

793

HOW DO YOU VALUE INTELLECTUAL PROPERTY?

795

Index

799

A

799

B

800

C

802

D

805

E

806

F

807

G

808

H

808

I

809

J

811

K

811

L

811

M

812

N

814

O

815

P

816

Q

818

R

818

S

818

T

821

U

822

V

823

W

823

X

823

Z

823